| 1BMO | e1bmoB1 | 108.1.1 | EF-hand | EF-hand-related | EF-hand | EF-hand_1 |
| e1bmoA1 | 108.1.1 | EF-hand | EF-hand-related | EF-hand | EF-hand_1 |
| e1bmoB2 | 379.1.1 | Kazal-type serine protease inhibitors-like | Kazal-type serine protease inhibitors | Kazal-type serine protease inhibitors | Kazal_1 |
| e1bmoA2 | 379.1.1 | Kazal-type serine protease inhibitors-like | Kazal-type serine protease inhibitors | Kazal-type serine protease inhibitors | Kazal_1 |
| e1bmoB3 | 389.1.1 | EGF-like | EGF-related | EGF/Laminin | EGF |
| e1bmoA3 | 389.1.1 | EGF-like | EGF-related | EGF/Laminin | EGF |
| 1NUB | e1nubB1 | 108.1.1 | EF-hand | EF-hand-related | EF-hand | EF-hand_1 |
| e1nubA1 | 108.1.1 | EF-hand | EF-hand-related | EF-hand | EF-hand_1 |
| e1nubA2 | 379.1.1 | Kazal-type serine protease inhibitors-like | Kazal-type serine protease inhibitors | Kazal-type serine protease inhibitors | Kazal_1 |
| e1nubB2 | 379.1.1 | Kazal-type serine protease inhibitors-like | Kazal-type serine protease inhibitors | Kazal-type serine protease inhibitors | Kazal_1 |
| e1nubB3 | 389.1.1 | EGF-like | EGF-related | EGF/Laminin | EGF |
| e1nubA3 | 389.1.1 | EGF-like | EGF-related | EGF/Laminin | EGF |
| 1SRA | e1sraA1 | 108.1.1 | EF-hand | EF-hand-related | EF-hand | EF-hand_1 |
| 2V53 | e2v53A1 | 108.1.1 | EF-hand | EF-hand-related | EF-hand | EF-hand_1 |
| e2v53A2 | 379.1.1 | Kazal-type serine protease inhibitors-like | Kazal-type serine protease inhibitors | Kazal-type serine protease inhibitors | Kazal_1 |
| e2v53A3 | 389.1.1 | EGF-like | EGF-related | EGF/Laminin | EGF |